These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33792733)

  • 21. New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding.
    Riffet M; Dupont B; Faisant M; Cerasuolo D; Menahem B; Alves A; Dubois F; Levallet G; Bazille C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological significance of poorly differentiated clusters in colorectal adenocarcinoma].
    Yang LL; Gou SQ; Wang JS; Qi Q; Huang WB
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):276-281. PubMed ID: 30955262
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
    Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
    JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
    Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
    Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
    Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
    Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Oh BY; Park YA; Huh JW; Yun SH; Kim HC; Chun HK; Kim SH; Ha SY; Lee WY; Cho YB
    Ann Surg Oncol; 2018 Jan; 25(1):204-211. PubMed ID: 29086140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative risk factors for survival outcomes in elective colorectal cancer surgery: a retrospective cohort study.
    Liu XX; Su J; Long YY; He M; Zhu ZQ
    BMC Gastroenterol; 2021 Apr; 21(1):169. PubMed ID: 33849450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.
    Zaanan A; Shi Q; Taieb J; Alberts SR; Meyers JP; Smyrk TC; Julie C; Zawadi A; Tabernero J; Mini E; Goldberg RM; Folprecht G; Van Laethem JL; Le Malicot K; Sargent DJ; Laurent-Puig P; Sinicrope FA
    JAMA Oncol; 2018 Mar; 4(3):379-383. PubMed ID: 28983557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Side specific differences of tumor budding on non-metastatic colon cancer.
    Sogutcu N; Gumus S; Abidin Balkan AZ; Bilge H; Cakabay B
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7649-7655. PubMed ID: 36314336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphangiosis as a predictor of outcome in patients with primary diffusely infiltrative adenocarcinoma of the colon and rectum.
    Tang R; Wang JY; Tsao KC; Ho YS
    Arch Surg; 1999 Feb; 134(2):157-60. PubMed ID: 10025455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
    Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
    [No Abstract]   [Full Text] [Related]  

  • 39. Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
    Cheng E; Shi Q; Shields AF; Nixon AB; Shergill AP; Ma C; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi SS; Ng K; O'Reilly EM; Brown JC; Philip PA; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA
    JAMA Oncol; 2023 Mar; 9(3):404-413. PubMed ID: 36701146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
    de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
    JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.